MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199
Benito, Juliana M., Godfrey, Laura, Kojima, Kensuke, Hogdal, Leah, Wunderlich, Mark, Geng, Huimin, Marzo, Isabel, Harutyunyan, Karine G., Golfman, Leonard, North, Phillip, Kerry, Jon, Ballabio, Erica, Chonghaile, Triona Ní, Gonzalo, Oscar, Qiu, Yihua, Jeremias, Irmela, Debose, LaKiesha, O’Brien, Eric, Ma, Helen, Zhou, Ping, Jacamo, Rodrigo, Park, Eugene, Coombes, Kevin R., Zhang, Nianxiang, Thomas, Deborah A., O’Brien, Susan, Kantarjian, Hagop M., Leverson, Joel D., Kornblau, Steven M., Andreeff, Michael, Müschen, Markus, Zweidler-McKay, Patrick A., Mulloy, James C., Letai, Anthony, Milne, Thomas A., Konopleva, Marina
Published in Cell reports (Cambridge) (29.12.2015)
Published in Cell reports (Cambridge) (29.12.2015)
Get full text
Journal Article
Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia
KONOPLEVA, Marina Y, WALTER, Roland B, HONGBO LU, DEBOSE, Lakiesha, BURGER, Jan A, ANDREEFF, Michael, WENBIN LIU, BAGGERLY, Keith A, KORNBLAU, Steven M, DOYLE, L. Austin, ESTEY, Elihu H, KANTARJIAN, Hagop M, FADERL, Stefan H, JABBOUR, Elias J, ZHIHONG ZENG, BORTHAKUR, Gautam, XUELIN HUANG, KADIA, Tapan M, RUVOLO, Peter P, FELIU, Jennie B
Published in Clinical cancer research (15.04.2014)
Published in Clinical cancer research (15.04.2014)
Get full text
Journal Article
Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemias
Ragon, Brittany Knick, Kantarjian, Hagop, Jabbour, Elias, Ravandi, Farhad, Cortes, Jorge, Borthakur, Gautam, DeBose, LaKiesha, Zeng, Zhihong, Schneider, Heather, Pemmaraju, Naveen, Garcia‐Manero, Guillermo, Kornblau, Steven, Wierda, William, Burger, Jan, DiNardo, Courtney D, Andreeff, Michael, Konopleva, Marina, Daver, Naval
Published in American journal of hematology (01.01.2017)
Published in American journal of hematology (01.01.2017)
Get full text
Journal Article
Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myeloid Leukemia
Konopleva, Marina Y., Walter, Roland B., Faderl, Stefan H., Jabbour, Elias J., Zeng, Zhihong, Borthakur, Gautam, Huang, Xuelin, Kadia, Tapan M., Ruvolo, Peter P., Feliu, Jennie B., Lu, Hongbo, Debose, LaKiesha, Burger, Jan A., Andreeff, Michael, Liu, Wenbin, Baggerly, Keith A., Kornblau, Steven M., Doyle, L. Austin, Estey, Elihu H., Kantarjian, Hagop M.
Published in Clinical cancer research (28.02.2014)
Published in Clinical cancer research (28.02.2014)
Get full text
Journal Article
Acute Lymphoblastic Leukemia Is a Bcl-2 Dependent Disease: Proteomic Profiling and Pre-Clinical Efficacy Of a Selective Bcl-2 Antagonist ABT-199
Konopleva, Marina, Benito, Juliana M, Harutyunyan, Karine G., Marzo, Isabel, Debose, LaKiesha, Gonzalo, Oscar, Zhou, Ping, Jacamo, Rodrigo, Park, Eugene, Muschen, Markus, Mulloy, James C., Bendall, Linda J, Zweidler-McKay, Patrick A, Coombes, Kevin R., Qiu, Yihua, Zhang, Nianxiang, Leverson, Joel, Thomas, Deborah A., O'Brien, Susan, Kantarjian, Hagop M., Kornblau, Steven M., Andreeff, Michael
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article